Article, see p 1770 B rain injury remains an important and potentially preventable complication of cardiac surgery. Although clinically overt strokes occur in a minority of patients, studies using frequent neurological assessments after surgery have found a much higher rate than had been previously appreciated.
Perioperative cerebral infarction associated with cardiac operations can be attributed to preexisting vascular disease, transient hypercoagulability, procedurerelated thromboembolism, hypoperfusion, or a combination of these factors. Among these mechanisms, hypoperfusion stands out as an obvious modifiable risk factor. Early observational studies found an association between the incidence and severity of postoperative brain damage and low mean arterial pressure (MAP) during cardiopulmonary bypass (CPB). 4, 5 Subsequent brain imaging studies suggested that up to 48% of cardiac surgical patients with postoperative stroke had infarction in the watershed regions of the brain and that hypotension was a risk factor for stroke. 6 Furthermore, although thromboembolism is an important mechanism for stroke, hypotension may exacerbate these injuries by impairing "washout" or clearance of microemboli. 7 However, randomized controlled studies [8] [9] [10] and observational studies 11, 12 have yielded inconclusive or conflicting results on the effect of MAP on outcomes, possibly because neurodiagnostic imaging was not among the primary end points.
In the PPCI (Perfusion Pressure Cerebral Infarcts) trial reported by Vedel et al 13 in this issue of Circulation, the investigators sought to answer whether increasing MAP with vasoconstrictors during CPB was effective for preventing perioperative cerebral infarction. The study methodology and end points were generally adherent to the recent neurological Academic Research Consortium's recommendations to capture the full spectrum of neurovascular injuries that occur during cardiovascular procedures. 3 Patients were tested for both overt stroke with neurological examinations and covert brain injury with DWI, as well as neurocognitive testing to detect postoperative decline. With this comprehensive approach, their findings support other recent studies showing that cerebral infarction was common and detectable in >50% of patients. Consistent with most prior studies, the majority of the infarcts were quite small (median, 0.027 cm 3 ), and border-zone infarcts were present in about one third of subjects. In addition, early postoperative cognitive deficits were frequent, present in 28% of patients. Of greatest importance, the investigation found that use of vasopressors to maintain the MAP in the range of 70 to 80 mm Hg during CPB compared with 40 to 50 mm Hg failed to decrease the incidence or severity of brain injury based on clinical strokes, the number and volume of acute infarcts detected by DWI, or the incidence of postoperative cognitive decline.
This thoughtfully designed and carefully executed study strongly suggests that augmenting MAP during CPB alone will not attenuate brain injury. This finding is concordant with some of the prior randomized trials of blood pressure management during CPB. 8, 9 In addition, previous studies that have failed to demonstrate the benefits of intraoperative cerebral oximetry also have suggested that hypoperfusion events may play only a minor role in the development of radiographic evidence of cerebral infarction after surgery. 14, 15 One critical difference between the PPCI study and 2 prior trials that did find significant differences in outcome for different blood pressure targets was that no vasodilator drugs were administered to the low-target group to deliberately decrease the MAP. Nitroglycerin or nitroprusside was administered to the low arterial pressure group in the study by Gold et al, 8 whereas uridil, an α-adrenergic antagonist, was administered to the lowpressure group in the study by Siepe et al. 10 It is possible that deliberate interventions to decrease MAP were a factor that influenced the outcomes between the lowand high-pressure groups in these prior studies rather than the deliberate interventions to increase the arterial pressure in the PPCI.
Despite a difference of 22.1 mm Hg in the MAP that was achieved between cohorts in the study, the wide variation in the range of cerebral autoregulation among individual patients may have attenuated the ability to demonstrate differences in outcomes. Existing studies indicate that the lower limit of cerebral autoregulation varies widely among individual cardiac surgical patients, with a 95% confidence interval of 43 to 90 mm Hg. Thus, the low-target MAP may not have been harmful for some patients in that cohort, whereas the high-target MAP may have been too high for some patients in that cohort. 16 In addition, the MAP was above the target range in 5 patients (5%) in the low-target group, and the MAP could not be achieved in 18 patients (19%) in the high-target group despite maximum doses of phenylephrine and norepinephrine. This particular finding raises the question of whether the site of arterial pressure measurement underestimated the true central aortic pressures and whether high-dose vasopressor treatment itself was harmful. Although not statistically significant, there were a greater number of patients with overt stroke, a greater proportion with cognitive dysfunction at 30 days, more patients with postoperative acute kidney injury, and higher mortality in the high-target group. Thus, interfering with autoregulation or artificially targeting a predefined blood pressure goal for every patient, whether it is high or low in the presence of fixed CPB flow, may not be advantageous.
Additional issues such as the exclusion of patients with prior stroke or transient ischemic attack may have contributed to the negative result of this trial. Preexisting cerebrovascular disease likely would have increased the susceptibility to cerebral hypoperfusion. Furthermore, as with all studies of brain imaging after cardiac surgery, there was a delay between the procedure and the magnetic resonance imaging of 3 to 5 days to allow the patient to stabilize and to be more likely to tolerate the study. Acute infarcts detected on DWI may have occurred at any time within the preceding 10 to 14 days. Thus, the injuries detected by DWI may not have occurred during CPB. For example, 3 clinically overt strokes occurred in the postoperative period, not during CPB. It is also possible that the hemodynamic management of patients after CPB affects the incidence or evolution of strokes. Thus, intervention to control MAP only during CPB may have been insufficient to generate differences in outcome.
Finally, although the authors report that the majority of infarcts appeared within border-zone regions, they failed to distinguish between cortical and internal border-zone infarcts. There is accumulated evidence that infarcts in the distribution of the cortical border zones, at the superficial junctures between major intracranial vascular territories, are more likely to be related to thromboembolism. 17 In contrast, internal border-zone infarcts, involving the smallest subcortical vessels at the junctures of the major intracranial arteries with the perforating Heubner, lenticulostriate, and anterior choroidal artery territories, tend to be caused by perfusion failure. 17 Analysis of the DWI scans of patients undergoing surgical aortic valve replacement found that 67% of strokes were embolic, 22% were both embolic and watershed, and only 3% were watershed alone. 18 Thus, it is possible that although the overall infarct rate was similar between the groups, the percentage of patients with internal border-zone hypoperfusion-related watershed strokes may have been higher in the low-target cohort, whereas cortical border-zone microembolirelated infarcts were higher in the high-target group. A higher MAP nadir was identified as a risk factor for clinical stroke in the prospective DeNOVO study (Determining Neurologic Outcomes from Valve Operations) of surgical aortic valve replacement, suggesting that higher pressure may be associated with increased risk of embolism. 1 The authors concluded that the findings of the PPCI trial refute the "washout" hypothesis that hypoperfusion impedes the clearance of emboli within the cerebral vasculature, which may be the case, but it is difficult to draw that conclusion without further analysis of the type of border-zone infarct.
The PPCI study provides important data on the incidence, severity, and mechanisms of brain injury as a consequence of cardiac operations performed with CPB. Furthermore, the inability to demonstrate any positive benefits of vasopressor therapy to maintain a higher MAP during CPB suggests that autoregulation within accepted norms for blood pressure is likely the best management approach for patients without a history of cerebrovascular disease. However, many questions remain, and additional efforts to decrease the incidence and severity of brain injury associated with cardiac operations are needed because this will continue to be an important issue for patients and their physicians.
